Global Infectious Bursal Disease Vaccine Market Growth 2021-2027
According to this latest study, the 2021 growth of Infectious Bursal Disease Vaccine will have significant change from previous year. By the most conservative estimates of global Infectious Bursal Disease Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Infectious Bursal Disease Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2027.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Bursal Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2027 in section 11.7.
Live
Inactivated
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2027 in section 11.8.
Veterinary Pharmacy
Online Sale
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infectious Bursal Disease Vaccine Consumption 2016-2026
2.1.2 Infectious Bursal Disease Vaccine Consumption CAGR by Region
2.2 Infectious Bursal Disease Vaccine Segment by Type
2.2.1 Live
2.2.2 Inactivated
2.3 Infectious Bursal Disease Vaccine Sales by Type
2.3.1 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Infectious Bursal Disease Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Infectious Bursal Disease Vaccine Sale Price by Type (2016-2021)
2.4 Infectious Bursal Disease Vaccine Segment by Distribution Channel
2.4.1 Veterinary Pharmacy
2.4.2 Online Sale
2.4.3 Others
2.5 Infectious Bursal Disease Vaccine Sales by Distribution Channel
2.5.1 Global Infectious Bursal Disease Vaccine Sale Market Share by Distribution Channel (2016-2021)
2.5.2 Global Infectious Bursal Disease Vaccine Revenue and Market Share by Distribution Channel (2016-2021)
2.5.3 Global Infectious Bursal Disease Vaccine Sale Price by Distribution Channel (2016-2021)
3 Global Infectious Bursal Disease Vaccine by Company
3.1 Global Infectious Bursal Disease Vaccine Sales Market Share by Company
3.1.1 Global Infectious Bursal Disease Vaccine Sales by Company (2019-2021)
3.1.2 Global Infectious Bursal Disease Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Company
3.2.1 Global Infectious Bursal Disease Vaccine Revenue by Company (2019-2021)
3.2.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Infectious Bursal Disease Vaccine Sale Price by Company
3.4 Global Manufacturers Infectious Bursal Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infectious Bursal Disease Vaccine Product Location Distribution
3.4.2 Players Infectious Bursal Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Infectious Bursal Disease Vaccine by Region
4.1 Global Infectious Bursal Disease Vaccine by Region
4.1.1 Global Infectious Bursal Disease Vaccine Sales by Region
4.1.2 Global Infectious Bursal Disease Vaccine Revenue by Region
4.2 Americas Infectious Bursal Disease Vaccine Sales Growth
4.3 APAC Infectious Bursal Disease Vaccine Sales Growth
4.4 Europe Infectious Bursal Disease Vaccine Sales Growth
4.5 Middle East & Africa Infectious Bursal Disease Vaccine Sales Growth
5 Americas
5.1 Americas Infectious Bursal Disease Vaccine Sales by Country
5.1.1 Americas Infectious Bursal Disease Vaccine Sales by Country (2016-2021)
5.1.2 Americas Infectious Bursal Disease Vaccine Revenue by Country (2016-2021)
5.2 Americas Infectious Bursal Disease Vaccine Sales by Type
5.3 Americas Infectious Bursal Disease Vaccine Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Bursal Disease Vaccine Sales by Region
6.1.1 APAC Infectious Bursal Disease Vaccine Sales by Region (2016-2021)
6.1.2 APAC Infectious Bursal Disease Vaccine Revenue by Region (2016-2021)
6.2 APAC Infectious Bursal Disease Vaccine Sales by Type
6.3 APAC Infectious Bursal Disease Vaccine Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Bursal Disease Vaccine by Country
7.1.1 Europe Infectious Bursal Disease Vaccine Sales by Country (2016-2021)
7.1.2 Europe Infectious Bursal Disease Vaccine Revenue by Country (2016-2021)
7.2 Europe Infectious Bursal Disease Vaccine Sales by Type
7.3 Europe Infectious Bursal Disease Vaccine Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Bursal Disease Vaccine by Country
8.1.1 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type
8.3 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Infectious Bursal Disease Vaccine Distributors
10.3 Infectious Bursal Disease Vaccine Customer
11 Global Infectious Bursal Disease Vaccine Market Forecast
11.1 Global Infectious Bursal Disease Vaccine Forecast by Region
11.1.1 Global Infectious Bursal Disease Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Infectious Bursal Disease Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Infectious Bursal Disease Vaccine Forecast by Type
11.7 Global Infectious Bursal Disease Vaccine Forecast by Distribution Channel
12 Key Players Analysis
12.1 Zoetis
12.1.1 Zoetis Company Information
12.1.2 Zoetis Infectious Bursal Disease Vaccine Product Offered
12.1.3 Zoetis Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Zoetis Main Business Overview
12.1.5 Zoetis Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Infectious Bursal Disease Vaccine Product Offered
12.2.3 Merck Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Elanco
12.3.1 Elanco Company Information
12.3.2 Elanco Infectious Bursal Disease Vaccine Product Offered
12.3.3 Elanco Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Elanco Main Business Overview
12.3.5 Elanco Latest Developments
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Company Information
12.4.2 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Offered
12.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Boehringer Ingelheim Main Business Overview
12.4.5 Boehringer Ingelheim Latest Developments
12.5 Ceva
12.5.1 Ceva Company Information
12.5.2 Ceva Infectious Bursal Disease Vaccine Product Offered
12.5.3 Ceva Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Ceva Main Business Overview
12.5.5 Ceva Latest Developments
12.6 Qingdao Yibang Biological Engineering Co., Ltd.
12.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Information
12.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
12.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Main Business Overview
12.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Latest Developments
12.7 Shandong Lvdu Biological Technology Co., Ltd.
12.7.1 Shandong Lvdu Biological Technology Co., Ltd. Company Information
12.7.2 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
12.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Shandong Lvdu Biological Technology Co., Ltd. Main Business Overview
12.7.5 Shandong Lvdu Biological Technology Co., Ltd. Latest Developments
12.8 Plyco Bioengineering Co., Ltd.
12.8.1 Plyco Bioengineering Co., Ltd. Company Information
12.8.2 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
12.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Plyco Bioengineering Co., Ltd. Main Business Overview
12.8.5 Plyco Bioengineering Co., Ltd. Latest Developments
12.9 Ruipu Biopharmaceutical Co., Ltd.
12.9.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
12.9.2 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
12.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Ruipu Biopharmaceutical Co., Ltd. Main Business Overview
12.9.5 Ruipu Biopharmaceutical Co., Ltd. Latest Developments
12.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
12.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
12.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
12.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business Overview
12.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Infectious Bursal Disease Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Live
Table 3. Major Players of Inactivated
Table 4. Global Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 5. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2021)
Table 6. Global Infectious Bursal Disease Vaccine Revenue by Type (2016-2021) & ($ million)
Table 7. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2021)
Table 8. Global Infectious Bursal Disease Vaccine Sale Price by Type (2016-2021)
Table 9. Global Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 10. Global Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 11. Global Infectious Bursal Disease Vaccine Value by Distribution Channel (2016-2021)
Table 12. Global Infectious Bursal Disease Vaccine Revenue Market Share by Distribution Channel (2016-2021)
Table 13. Global Infectious Bursal Disease Vaccine Sale Price by Distribution Channel (2016-2021)
Table 14. Global Infectious Bursal Disease Vaccine Sales by Company (2019-2021) & (K Units)
Table 15. Global Infectious Bursal Disease Vaccine Sales Market Share by Company (2019-2021)
Table 16. Global Infectious Bursal Disease Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Infectious Bursal Disease Vaccine Revenue Market Share by Company (2019-2021)
Table 18. Global Infectious Bursal Disease Vaccine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Infectious Bursal Disease Vaccine Producing Area Distribution and Sales Area
Table 20. Players Infectious Bursal Disease Vaccine Products Offered
Table 21. Infectious Bursal Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Infectious Bursal Disease Vaccine Sales by Region (2016-2021) (K Units)
Table 25. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2016-2021)
Table 26. Global Infectious Bursal Disease Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2016-2021)
Table 28. Americas Infectious Bursal Disease Vaccine Sales by Country (2016-2021) & (K Units)
Table 29. Americas Infectious Bursal Disease Vaccine Sales Market Share by Country (2016-2021)
Table 30. Americas Infectious Bursal Disease Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Infectious Bursal Disease Vaccine Revenue Market Share by Country (2016-2021)
Table 32. Americas Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 33. Americas Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2021)
Table 34. Americas Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 35. Americas Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 36. APAC Infectious Bursal Disease Vaccine Sales by Region (2016-2021) & (K Units)
Table 37. APAC Infectious Bursal Disease Vaccine Sales Market Share by Region (2016-2021)
Table 38. APAC Infectious Bursal Disease Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Infectious Bursal Disease Vaccine Revenue Market Share by Region (2016-2021)
Table 40. APAC Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 41. APAC Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2021)
Table 42. APAC Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 43. APAC Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 44. Europe Infectious Bursal Disease Vaccine Sales by Country (2016-2021) & (K Units)
Table 45. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country (2016-2021)
Table 46. Europe Infectious Bursal Disease Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country (2016-2021)
Table 48. Europe Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 49. Europe Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2021)
Table 50. Europe Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 51. Europe Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 52. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 59. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 60. Key and Potential Regions of Infectious Bursal Disease Vaccine
Table 61. Key Application and Potential Industries of Infectious Bursal Disease Vaccine
Table 62. Key Challenges of Infectious Bursal Disease Vaccine
Table 63. Key Trends of Infectious Bursal Disease Vaccine
Table 64. Infectious Bursal Disease Vaccine Distributors List
Table 65. Infectious Bursal Disease Vaccine Customer List
Table 66. Global Infectious Bursal Disease Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Infectious Bursal Disease Vaccine Consumption Market Forecast by Region
Table 68. Global Infectious Bursal Disease Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Infectious Bursal Disease Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Infectious Bursal Disease Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Infectious Bursal Disease Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Infectious Bursal Disease Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Infectious Bursal Disease Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Infectious Bursal Disease Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Infectious Bursal Disease Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Infectious Bursal Disease Vaccine Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Infectious Bursal Disease Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Infectious Bursal Disease Vaccine Sales Forecast by Distribution Channel (2021-2026) & (K Units)
Table 83. Global Infectious Bursal Disease Vaccine Sales Market Share Forecast by Distribution Channel (2021-2026)
Table 84. Global Infectious Bursal Disease Vaccine Revenue Forecast by Distribution Channel (2021-2026) & ($ Millions)
Table 85. Global Infectious Bursal Disease Vaccine Revenue Market Share Forecast by Distribution Channel (2021-2026)
Table 86. Zoetis Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Zoetis Infectious Bursal Disease Vaccine Product Offered
Table 88. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Zoetis Main Business
Table 90. Zoetis Latest Developments
Table 91. Merck Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Infectious Bursal Disease Vaccine Product Offered
Table 93. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Merck Main Business
Table 95. Merck Latest Developments
Table 96. Elanco Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. Elanco Infectious Bursal Disease Vaccine Product Offered
Table 98. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. Elanco Main Business
Table 100. Elanco Latest Developments
Table 101. Boehringer Ingelheim Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Offered
Table 103. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Boehringer Ingelheim Main Business
Table 105. Boehringer Ingelheim Latest Developments
Table 106. Ceva Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. Ceva Infectious Bursal Disease Vaccine Product Offered
Table 108. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Ceva Main Business
Table 110. Ceva Latest Developments
Table 111. Qingdao Yibang Biological Engineering Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
Table 113. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Qingdao Yibang Biological Engineering Co., Ltd. Main Business
Table 115. Qingdao Yibang Biological Engineering Co., Ltd. Latest Developments
Table 116. Shandong Lvdu Biological Technology Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
Table 118. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. Shandong Lvdu Biological Technology Co., Ltd. Main Business
Table 120. Shandong Lvdu Biological Technology Co., Ltd. Latest Developments
Table 121. Plyco Bioengineering Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
Table 123. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Plyco Bioengineering Co., Ltd. Main Business
Table 125. Plyco Bioengineering Co., Ltd. Latest Developments
Table 126. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
Table 128. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 129. Ruipu Biopharmaceutical Co., Ltd. Main Business
Table 130. Ruipu Biopharmaceutical Co., Ltd. Latest Developments
Table 131. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Infectious Bursal Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Offered
Table 133. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 134. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Main Business
Table 135. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Infectious Bursal Disease Vaccine
Figure 2. Infectious Bursal Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infectious Bursal Disease Vaccine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Infectious Bursal Disease Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Infectious Bursal Disease Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Live
Figure 10. Product Picture of Inactivated
Figure 11. Global Infectious Bursal Disease Vaccine Sales Market Share by Type in 2020
Figure 12. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2021)
Figure 13. Infectious Bursal Disease Vaccine Consumed in Veterinary Pharmacy
Figure 14. Global Infectious Bursal Disease Vaccine Market: Veterinary Pharmacy (2016-2021) & (K Units)
Figure 15. Infectious Bursal Disease Vaccine Consumed in Online Sale
Figure 16. Global Infectious Bursal Disease Vaccine Market: Online Sale (2016-2021) & (K Units)
Figure 17. Infectious Bursal Disease Vaccine Consumed in Others
Figure 18. Global Infectious Bursal Disease Vaccine Market: Others (2016-2021) & (K Units)
Figure 19. Global Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel (2016-2021)
Figure 20. Global Infectious Bursal Disease Vaccine Revenue Market Share by Distribution Channel in 2020
Figure 21. Infectious Bursal Disease Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Infectious Bursal Disease Vaccine Revenue Market Share by Company in 2020
Figure 23. Global Infectious Bursal Disease Vaccine Sales Market Share by Regions (2016-2021)
Figure 24. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region in 2020
Figure 25. Americas Infectious Bursal Disease Vaccine Sales 2016-2021 (K Units)
Figure 26. Americas Infectious Bursal Disease Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. APAC Infectious Bursal Disease Vaccine Sales 2016-2021 (K Units)
Figure 28. APAC Infectious Bursal Disease Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Europe Infectious Bursal Disease Vaccine Sales 2016-2021 (K Units)
Figure 30. Europe Infectious Bursal Disease Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Infectious Bursal Disease Vaccine Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Infectious Bursal Disease Vaccine Revenue 2016-2021 ($ Millions)
Figure 33. Americas Infectious Bursal Disease Vaccine Sales Market Share by Country in 2020
Figure 34. Americas Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2020
Figure 35. Americas Infectious Bursal Disease Vaccine Sales Market Share by Type in 2020
Figure 36. Americas Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel in 2020
Figure 37. United States Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Infectious Bursal Disease Vaccine Sales Market Share by Region in 2020
Figure 42. APAC Infectious Bursal Disease Vaccine Revenue Market Share by Regions in 2020
Figure 43. APAC Infectious Bursal Disease Vaccine Sales Market Share by Type in 2020
Figure 44. APAC Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel in 2020
Figure 45. China Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country in 2020
Figure 52. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2020
Figure 53. Europe Infectious Bursal Disease Vaccine Sales Market Share by Type in 2020
Figure 54. Europe Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel in 2020
Figure 55. Germany Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Distribution Channel in 2020
Figure 64. Egypt Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Infectious Bursal Disease Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
